Stockholders’ Equity and Convertible Preferred Stock - Schedule of Warrant Activity (Details) - Warrant [Member] - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Mar. 31, 2026 |
|
| Schedule of Warrant Activity [Line Items] | ||
| Number of shares, ending balance | 6,690,768 | 6,362,098 |
| Weighted Average per share, ending balance | $ 5.38 | $ 4.25 |
| Outstanding ending balance, Total Intrinsic Value | $ 6,186 | |
| Outstanding ending balance, Weighted Average Remaining Contractual Life | 3 years 10 months 24 days | 3 years 9 months 18 days |
| Granted, Warrants | ||
| Granted, Weighted Average Exercise Price | ||
| Granted, Total Intrinsic Value | ||
| Granted, Weighted Average Remaining Contractual Life | ||
| Expired, Warrants | (253,670) | |
| Expired, Weighted Average Exercise Price | $ 34 | |
| Expired, Total Intrinsic Value | ||
| Expired, Weighted Average Remaining Contractual Life (in years) | ||
| Exercised, Warrants | (75,000) | |
| Exercised, Weighted Average Exercise Price | $ 4.22 | |
| Exercised, Total Intrinsic Value |
| X | ||||||||||
- Definition Exercised, warrants. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards expired during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
- Definition Expired, warrants. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options expired, weighted average remaining contractual life. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options grants weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Exercised, weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Exercised, total intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of expired award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Amount of aggregate intrinsic value grants under other than options. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|